GlassScriptPhysician profile
Lisa S Sward
NPI 1174688279
$1,134.86
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $11.07 · 2022: $13.76 · 2023: $354 · 2024: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $213.81 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $161.81 | 2023-2024 | Qulipta, Vraylar, Ubrelvy |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $109.99 | 2023-2024 | Arexvy, Shingrix, Flulaval Quadrivalent |
| Pfizer INC. | $85.24 | 2023-2024 | |
| Lilly USA, LLC | $74.39 | 2023-2024 | Mounjaro, Jardiance |
| Rxsight INC | $58.41 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Abbott Laboratories | $49.36 | 2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.91 | 2024 | Ofev |
| Amgen INC. | $46.34 | 2023-2024 | Evenity, Repatha, Otezla |
| Axsome Therapeutics, INC. | $29.35 | 2023 | Auvelity |
| Phathom Pharmaceuticals, INC. | $27.70 | 2024 | Voquezna |
| Janssen Pharmaceuticals, INC | $26.47 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $26.05 | 2020-2024 | Breztri |
| Ethicon US, LLC | $24.76 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.52 | 2024 | |
| Scilex Pharmaceuticals INC. | $13.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Sward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.